Megadose methyprednisolone for the treatment of patients with Evans syndrome

Pediatric Hematology and Oncology

Volumn 21, Issue 8, 2004, Pages 739-740

  Özsoylu, Fiinasi ^a,b  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BOLUS INJECTION; BRAIN HEMORRHAGE; CHILD; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; SHORT COURSE THERAPY; DRUG ADMINISTRATION; NOTE; SYNDROME; THROMBOCYTOPENIC PURPURA;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; DRUG ADMINISTRATION SCHEDULE; HUMANS; METHYLPREDNISOLONE; PURPURA, THROMBOCYTOPENIC; SYNDROME;

EID: 15744388261     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010490514778     Document Type: Article

References (6)

1. Ruggiero A, Piestra M, Casedei Pistill AM, et al. Spontaneous fatal intracranial hemorrhage in a child with Evans syndrome. Pediatr Hematol Oncol. 2003;20:403-408.
2. Özsoylu F. Megadose methylprednisolone for Evans syndrome. Pediatr Hematol Oncol. 2000;17: 727-728.
3. Özsoylu F, Ertürk G. Oral versus intravenous megadose of methylprednisolone for childhood idiopathic thrombocytopenia purpura. Blood. 1991;77:1856.
4. Özsoylu F. High dose intravenous methylprednisolone (HIVMP) in haematologic disorders. Hematol Rev. 1990;4:197-207.
5. Hiçsönmez G, Özsoylu F, Gürgey A, et al. High dose methylprednisolone for remission induction in children with acute non-lymphoblastic leukemia. Eur J Haematol. 1989;42:498-501.
6. Bernini JC, Carillo JM, Buchanan GR. High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednosone. J Pediatr. 1995;127:654-659.